Natus Sensory, Inc.

Natus Sensory, Inc. is a US-based company focused on developing innovative diagnostic solutions for hearing, balance, and vision assessment, catering primarily to healthcare professionals worldwide. Natus Sensory, Inc. specializes in providing diagnostic solutions for sensory assessments.

Founded in 2023 in the US, the company is headed by CEO Peter Reimer. There are no records of significant pivots or mergers. The company is dedicated to advancing the field through specialized product offerings. Natus Sensory specializes in innovative solutions for the assessment and screening of hearing, balance, and vision, primarily serving healthcare professionals globally.

Their core product offerings include advanced audiometers, tympanometers, auditory evoked potentials devices, and diagnostic otoacoustic emissions systems, which facilitate comprehensive hearing assessments. In addition, their hearing aid fitting systems, such as the Aurical® platform, enhance the fitting process with modular components for efficiency. The company also provides balance assessment tools like the ICS® Dizcovery, which integrates videonystagmography technology for detailed diagnostic insights. Vision screening products, including the RetCam® Envision system, are designed for pediatric ocular imaging.

These products are distributed across various international markets, serving hospitals, clinics, and private practices in regions such as North America, Europe, and Asia-Pacific. Natus Sensory generates revenue through direct sales and partnerships with healthcare institutions, focusing on B2B transactions. Their business model includes the sale of flagship products such as the Aurical® hearing aid fitting system and the ICS® Dizcovery balance assessment solution, which are priced according to their specialized technology and the support services they offer. The company may engage in subscription models for software solutions and training academies, providing ongoing education and support to their client base.

Revenue is further supplemented through service programs aimed at maintaining and calibrating their diagnostic equipment, ensuring continued functionality in clinical settings. The structured approach to client relationships supports a recurring revenue stream through both product sales and service agreements.